Recruiting
Myelodysplastic syndrome+1
RecruitingStudy on Metformin for Preventing Leukemia in Patients with Clonal Cytopenia and Low-Risk Myelodysplastic Syndromes
Registered drugNo placebo
Study on Metformin for Preventing Leukemia in Patients with Clonal Cytopenia and Low-Risk Myelodysplastic Syndromes
Registered drugNo placebo
- Disease:Myelodysplastic syndromeClonal cytopenia of undetermined significance
- Substances:Metformin Hydrochloride
Countries:
Denmark
Denmark- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:Metformin Hydrochloride
- Sponsor:Rigshospitalet
